SABS
SAB Biotherapeutics Inc. Common Stock
$1.831+0.000 (0.000%)
Real-time Price
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.831
High
$1.831
Low
$1.831
Volume
0.01M
Company Fundamentals
Trading Stats
Related News
Analyst Upgrades
Chardan Capital Maintains Buy on SAB Biotherapeutics, Maintains $20 Price Target
Chardan Capital analyst Keay Nakae maintains SAB Biotherapeutics with a Buy and maintains $20 price target.
View more
Analyst Upgrades
HC Wainwright & Co. Assumes SAB Biotherapeutics at Buy, Announces Price Target of $10
HC Wainwright & Co. analyst Emily Bodnar assumes SAB Biotherapeutics with a Buy rating and announces Price Target of $10.
View more
Related Stocks
AAME
Atlantic American Corporation
NASDAQ
Life Insurance
BSX
Boston Scientific
SP500
Health Care Equ...
EQC
Equity Commonwealth Common Shares of Beneficial Interest
NASDAQ
Real Estate Inv...
CNP
CenterPoint Energy Inc (Holding Co)
NASDAQ
Electric Utilit...
EDSA
Edesa Biotech Inc. Common Shares
NASDAQ
Biotechnology: ...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.